Abstract

This study examined the association between race/ethnicity and health insurance payer type with pediatric opioid and non-opioid ordering in an inpatient hospital setting. Cross-sectional inpatient encounter data from June 2013 to June 2018 was retrieved from a pediatric children's hospital in Southern California (N = 55,944), and statistical analyses were performed to determine associations with opioid ordering. There was a significant main effect of race/ethnicity on opioid and non-opioid orders. Physicians ordered significantly fewer opioid medications, but a greater number of non-opioid medications, for non-Hispanic African American children than non-Hispanic Asian, Hispanic/Latinx, and non-Hispanic White pediatric patients. There was also a main effect of health insurance payer type on non-opioid orders. Patients with government-sponsored plans (e.g., Medi-Cal, Medicare) received fewer non-opioid prescriptions compared with patients with both HMO and PPO coverage. Additionally, there was a significant race/ethnicity by insurance interaction on opioid orders. Non-Hispanic White patients with "other" insurance coverage received the greatest number of opioid orders. In non-Hispanic African American patients, children with PPO coverage received fewer opioids than those with government-sponsored and HMO insurance. For non-Hispanic Asian patients, children with PPO were prescribed more opioids than those with government-sponsored and HMO coverage. Findings suggest that the relationship between race/ethnicity, insurance type, and physician decisions opioid prescribing is complex and multifaceted. Given that consistency in opioid prescribing should be seen regardless of patient background characteristics, future studies should continue to assess and monitor unequitable differences in care.

Highlights

  • The unprecedented rates of opioid misuse and related deaths in the USA have commanded the attention of public health professionals and governmental health agencies [1]

  • Findings suggest that the relationship between race/ethnicity, insurance type, and physician decisions opioid prescribing is complex and multifaceted

  • Given that research examining differences in pediatric inpatient opioid use based on patient race/ethnicity and health insurance payer type is crucial for promoting appropriate and safe pain management across diverse social and demographic sectors, this study focused on identifying the multifaceted association of race/ethnicity and health insurance payer type with both physician opioid and non-opioid ordering for pediatric patients

Read more

Summary

Introduction

The unprecedented rates of opioid misuse and related deaths in the USA have commanded the attention of public health professionals and governmental health agencies [1]. It was reported that the death rate from abuse of opioids quadrupled between 1999 and 2010, a rate which continues to increase and plague the nation [2, 3]. In 2016 alone, the USA reported over 42,000 fatal opioid overdoses, signifying a 27% increase in mortality rate from 2015 [4]. Pediatric opioid-related poisoning and deaths increased by 268% between 1999 and 2016, with the largest percent increase among children between ages 1 and 4 [5, 6]. This study examined the association between race/ethnicity and health insurance payer type with pediatric opioid and non-opioid ordering in an inpatient hospital setting

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call